The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Gaucher’s Disease Treatment Market Research Report 2025

Global Gaucher’s Disease Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1735992

No of Pages : 99

Ask Your Query

Synopsis
Global Gaucher’s Disease Treatment market is projected to reach US$ 1984.4 million in 2029, increasing from US$ 1550 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gaucher’s Disease Treatment market research.
Key manufacturers engaged in the Gaucher’s Disease Treatment industry include Amicus Therapeutics, Inc., Novartis AG, Shire plc, Actelion Pharmaceuticals Ltd., Protalix Bio Therapeutics Inc., Johnson & Johnson, Takeda Pharmaceutical Company Limited, Abbott Laboratories and Aptalis Pharma Inc., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Gaucher’s Disease Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Gaucher’s Disease Treatment market and estimated to attract more attentions from industry insiders and investors.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gaucher’s Disease Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Amicus Therapeutics, Inc.
  • Novartis AG
  • Shire plc
  • Actelion Pharmaceuticals Ltd.
  • Protalix Bio Therapeutics Inc.
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited
  • Abbott Laboratories
  • Aptalis Pharma Inc.
  • GSK Plc

Segment by Type

  • Enzyme Replacement Therapy
  • Substrate Reduction Therapy
  • Splenectomy
  • Orthopaedic Surgery
  • Gene Therapy
  • Others

Segment by Application

  • Clinic
  • Hospital
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia) 
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

The Gaucher’s Disease Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

List of Tables
Table 1. Global Gaucher’s Disease Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Gaucher’s Disease Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Gaucher’s Disease Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gaucher’s Disease Treatment Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Gaucher’s Disease Treatment Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Gaucher’s Disease Treatment Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Gaucher’s Disease Treatment Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Gaucher’s Disease Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Gaucher’s Disease Treatment, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Gaucher’s Disease Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gaucher’s Disease Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Gaucher’s Disease Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gaucher’s Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gaucher’s Disease Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gaucher’s Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Gaucher’s Disease Treatment Sales by Region (2018-2023) & (K Units)
Table 18. Global Gaucher’s Disease Treatment Sales Market Share by Region (2018-2023)
Table 19. Global Gaucher’s Disease Treatment Sales by Region (2024-2029) & (K Units)
Table 20. Global Gaucher’s Disease Treatment Sales Market Share by Region (2024-2029)
Table 21. Global Gaucher’s Disease Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Gaucher’s Disease Treatment Revenue Market Share by Region (2018-2023)
Table 23. Global Gaucher’s Disease Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Gaucher’s Disease Treatment Revenue Market Share by Region (2024-2029)
Table 25. North America Gaucher’s Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Gaucher’s Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 27. North America Gaucher’s Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 28. North America Gaucher’s Disease Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Gaucher’s Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Gaucher’s Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Gaucher’s Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 32. Europe Gaucher’s Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 33. Europe Gaucher’s Disease Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Gaucher’s Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Gaucher’s Disease Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Gaucher’s Disease Treatment Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Gaucher’s Disease Treatment Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Gaucher’s Disease Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Gaucher’s Disease Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gaucher’s Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Gaucher’s Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Gaucher’s Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Gaucher’s Disease Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Gaucher’s Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Gaucher’s Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Gaucher’s Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Gaucher’s Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Gaucher’s Disease Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Gaucher’s Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Gaucher’s Disease Treatment Sales (K Units) by Type (2018-2023)
Table 51. Global Gaucher’s Disease Treatment Sales (K Units) by Type (2024-2029)
Table 52. Global Gaucher’s Disease Treatment Sales Market Share by Type (2018-2023)
Table 53. Global Gaucher’s Disease Treatment Sales Market Share by Type (2024-2029)
Table 54. Global Gaucher’s Disease Treatment Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Gaucher’s Disease Treatment Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Gaucher’s Disease Treatment Revenue Market Share by Type (2018-2023)
Table 57. Global Gaucher’s Disease Treatment Revenue Market Share by Type (2024-2029)
Table 58. Global Gaucher’s Disease Treatment Price (US$/Unit) by Type (2018-2023)
Table 59. Global Gaucher’s Disease Treatment Price (US$/Unit) by Type (2024-2029)
Table 60. Global Gaucher’s Disease Treatment Sales (K Units) by Application (2018-2023)
Table 61. Global Gaucher’s Disease Treatment Sales (K Units) by Application (2024-2029)
Table 62. Global Gaucher’s Disease Treatment Sales Market Share by Application (2018-2023)
Table 63. Global Gaucher’s Disease Treatment Sales Market Share by Application (2024-2029)
Table 64. Global Gaucher’s Disease Treatment Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Gaucher’s Disease Treatment Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Gaucher’s Disease Treatment Revenue Market Share by Application (2018-2023)
Table 67. Global Gaucher’s Disease Treatment Revenue Market Share by Application (2024-2029)
Table 68. Global Gaucher’s Disease Treatment Price (US$/Unit) by Application (2018-2023)
Table 69. Global Gaucher’s Disease Treatment Price (US$/Unit) by Application (2024-2029)
Table 70. Amicus Therapeutics, Inc. Corporation Information
Table 71. Amicus Therapeutics, Inc. Description and Business Overview
Table 72. Amicus Therapeutics, Inc. Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Amicus Therapeutics, Inc. Gaucher’s Disease Treatment Product
Table 74. Amicus Therapeutics, Inc. Recent Developments/Updates
Table 75. Novartis AG Corporation Information
Table 76. Novartis AG Description and Business Overview
Table 77. Novartis AG Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Novartis AG Gaucher’s Disease Treatment Product
Table 79. Novartis AG Recent Developments/Updates
Table 80. Shire plc Corporation Information
Table 81. Shire plc Description and Business Overview
Table 82. Shire plc Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Shire plc Gaucher’s Disease Treatment Product
Table 84. Shire plc Recent Developments/Updates
Table 85. Actelion Pharmaceuticals Ltd. Corporation Information
Table 86. Actelion Pharmaceuticals Ltd. Description and Business Overview
Table 87. Actelion Pharmaceuticals Ltd. Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Actelion Pharmaceuticals Ltd. Gaucher’s Disease Treatment Product
Table 89. Actelion Pharmaceuticals Ltd. Recent Developments/Updates
Table 90. Protalix Bio Therapeutics Inc. Corporation Information
Table 91. Protalix Bio Therapeutics Inc. Description and Business Overview
Table 92. Protalix Bio Therapeutics Inc. Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Protalix Bio Therapeutics Inc. Gaucher’s Disease Treatment Product
Table 94. Protalix Bio Therapeutics Inc. Recent Developments/Updates
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Johnson & Johnson Gaucher’s Disease Treatment Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Takeda Pharmaceutical Company Limited Corporation Information
Table 101. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 102. Takeda Pharmaceutical Company Limited Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Takeda Pharmaceutical Company Limited Gaucher’s Disease Treatment Product
Table 104. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 105. Abbott Laboratories Corporation Information
Table 106. Abbott Laboratories Description and Business Overview
Table 107. Abbott Laboratories Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Abbott Laboratories Gaucher’s Disease Treatment Product
Table 109. Abbott Laboratories Recent Developments/Updates
Table 110. Aptalis Pharma Inc. Corporation Information
Table 111. Aptalis Pharma Inc. Description and Business Overview
Table 112. Aptalis Pharma Inc. Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Aptalis Pharma Inc. Gaucher’s Disease Treatment Product
Table 114. Aptalis Pharma Inc. Recent Developments/Updates
Table 115. GSK Plc Corporation Information
Table 116. GSK Plc Description and Business Overview
Table 117. GSK Plc Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. GSK Plc Gaucher’s Disease Treatment Product
Table 119. GSK Plc Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Gaucher’s Disease Treatment Distributors List
Table 123. Gaucher’s Disease Treatment Customers List
Table 124. Gaucher’s Disease Treatment Market Trends
Table 125. Gaucher’s Disease Treatment Market Drivers
Table 126. Gaucher’s Disease Treatment Market Challenges
Table 127. Gaucher’s Disease Treatment Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gaucher’s Disease Treatment
Figure 2. Global Gaucher’s Disease Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Gaucher’s Disease Treatment Market Share by Type in 2022 & 2029
Figure 4. Enzyme Replacement Therapy Product Picture
Figure 5. Substrate Reduction Therapy Product Picture
Figure 6. Splenectomy Product Picture
Figure 7. Orthopaedic Surgery Product Picture
Figure 8. Gene Therapy Product Picture
Figure 9. Others Product Picture
Figure 10. Global Gaucher’s Disease Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Gaucher’s Disease Treatment Market Share by Application in 2022 & 2029
Figure 12. Clinic
Figure 13. Hospital
Figure 14. Others
Figure 15. Global Gaucher’s Disease Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Gaucher’s Disease Treatment Market Size (2018-2029) & (US$ Million)
Figure 17. Global Gaucher’s Disease Treatment Sales (2018-2029) & (K Units)
Figure 18. Global Gaucher’s Disease Treatment Average Price (US$/Unit) & (2018-2029)
Figure 19. Gaucher’s Disease Treatment Report Years Considered
Figure 20. Gaucher’s Disease Treatment Sales Share by Manufacturers in 2022
Figure 21. Global Gaucher’s Disease Treatment Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Gaucher’s Disease Treatment Players: Market Share by Revenue in 2022
Figure 23. Gaucher’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Gaucher’s Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America Gaucher’s Disease Treatment Sales Market Share by Country (2018-2029)
Figure 26. North America Gaucher’s Disease Treatment Revenue Market Share by Country (2018-2029)
Figure 27. United States Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Gaucher’s Disease Treatment Sales Market Share by Country (2018-2029)
Figure 30. Europe Gaucher’s Disease Treatment Revenue Market Share by Country (2018-2029)
Figure 31. Germany Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Gaucher’s Disease Treatment Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Gaucher’s Disease Treatment Revenue Market Share by Region (2018-2029)
Figure 38. China Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Gaucher’s Disease Treatment Sales Market Share by Country (2018-2029)
Figure 46. Latin America Gaucher’s Disease Treatment Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Colombia Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Gaucher’s Disease Treatment Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Gaucher’s Disease Treatment Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Gaucher’s Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Gaucher’s Disease Treatment by Type (2018-2029)
Figure 57. Global Revenue Market Share of Gaucher’s Disease Treatment by Type (2018-2029)
Figure 58. Global Gaucher’s Disease Treatment Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Gaucher’s Disease Treatment by Application (2018-2029)
Figure 60. Global Revenue Market Share of Gaucher’s Disease Treatment by Application (2018-2029)
Figure 61. Global Gaucher’s Disease Treatment Price (US$/Unit) by Application (2018-2029)
Figure 62. Gaucher’s Disease Treatment Value Chain
Figure 63. Gaucher’s Disease Treatment Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock